Brellier Ludovic 4

What Happened

• Ludovic Brellier, Executive Vice President, Bioscience & Medtech at Avantor (AVTR), received two equity awards on May 1, 2026: 146,566 restricted stock units (RSUs) and 246,002 stock options. Both awards are reported as acquisitions at $0.00 per share (awards/grants), meaning no cash was paid by the insider at grant. The option award is reported as a derivative instrument.

Key Details

• Transaction date: May 1, 2026; Form 4 filed May 5, 2026 (filing appears timely).
• RSUs: 146,566 shares granted at $0.00 (Footnote F1). Vesting: three equal annual installments beginning May 1, 2027.
• Stock options: 246,002 options granted at $0.00 (derivative) (Footnote F2). Vesting: three equal annual installments beginning May 1, 2027.
• Shares owned after transaction: not specified in the filing.
• Transaction code: A = Award/Grant. No 10b5-1 plan, tax-withholding, or late-filing flags were noted in the provided details.

Context

• These are standard equity compensation grants, not purchases or sales. RSUs convert to shares as they vest; stock options give the right to buy shares later (subject to the vesting schedule and any exercise price and plan terms). Such awards are routine for executive compensation and do not, by themselves, indicate immediate buying or selling activity.